[Clinical study on the effects of creatinol-O-phosphate in patients with heart diseases under digitalis treatment].
D000368:Aged; D000438:Alcohols / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D003401:Creatine / Q000627:therapeutic use*; D004357:Drug Synergism; D004361:Drug Tolerance; D005260:Female; D006212:Hallucinations / Q000139:chemically induced / Q000188:drug therapy; D006331:Heart Diseases / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007799:Lanatosides / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy; D009759:Nystagmus, Pathologic / Q000139:chemically induced / Q000188:drug therapy; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D014717:Vertigo / Q000139:chemically induced / Q000188:drug therapy
D000438:Alcohols; D007799:Lanatosides; D009943:Organophosphorus Compounds; D003401:Creatine
Studio clinico sugli effetti del creatinolo-O-fosfato in cardiopatici in trattamento digitalico.